NLRP12 and inflammatory bowel disease: The lack of a role for NLRP12 in the disease processes assessed here is encouraging from the aspect of pharmacological inhibitors that target other inflammatory disorders, such as contact hypersensitivity or inflammatory bowel disease, where NLRP12 was found to play a role in a disease model.